Company news

Supernus Pharmaceuticals, Inc. news in 2023

Supernus Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Supernus Announces Third Quarter 2023 Financial Results

November 7, 2023

Supernus to Participate in the Jefferies London Healthcare Conference

November 6, 2023

Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023

October 24, 2023

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey

October 15, 2023

Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City

September 26, 2023

Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms

September 8, 2023

Supernus to Participate in the Wells Fargo Healthcare Conference

August 30, 2023

Bethany L. Sensenig Joins Supernus’ Board of Directors

August 20, 2023

Supernus Announces Second Quarter 2023 Financial Results

August 7, 2023

Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023

July 23, 2023

Supernus to Participate in the Jefferies Healthcare Conference

May 30, 2023

Supernus Announces First Quarter 2023 Financial Results

May 8, 2023

Supernus to Present at the Bank of America 2023 Health Care Conference

May 1, 2023

Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023

April 24, 2023

Supernus Announces Repayment of Convertible Notes

April 2, 2023

Supernus to Present at the Cowen 43rd Annual Health Care Conference

February 28, 2023

Supernus Announces Fourth Quarter and Full Year 2022 Financial Results

February 27, 2023

Supernus Enters Into $150 Million Credit Facility

February 13, 2023

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 28, 2023

February 8, 2023

Calls in 2023

Decks in 2023